SAB BIOTHERAPEUTICS, INC. Equity Securities, FV-NI, Unrealized Gain
SAB BIOTHERAPEUTICS, INC. (SABS) reported Equity Securities, FV-NI, Unrealized Gain of $53.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGain · last filed 2025-05-09
- SAB BIOTHERAPEUTICS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2024-12-31 was $0.00.
- SAB BIOTHERAPEUTICS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2024-09-30 was $38.00K.
- SAB BIOTHERAPEUTICS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2024-06-30 was $7.00K.
- SAB BIOTHERAPEUTICS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2024-03-31 was $7.00K.
- SAB BIOTHERAPEUTICS, INC. equity securities, fv-ni, unrealized gain for fiscal 2024 was $53.00K.
| Period end | Equity Securities, FV-NI, Unrealized Gain 3 month | Equity Securities, FV-NI, Unrealized Gain 6 month | Equity Securities, FV-NI, Unrealized Gain 9 month | Equity Securities, FV-NI, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $38.00K derived: sum of 2 quarters · filed 2025-03-31 | $45.00K derived: sum of 3 quarters · filed 2025-03-31 | $53.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $38.00K 10-Q · filed 2024-11-06 | $45.00K derived: sum of 2 quarters · filed 2024-11-06 | $53.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $7.00K 10-Q · filed 2024-08-08 | $15.00K 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |